UEPS Stock UPDATES Net 1 Ueps Technologies (UEPS) 13.71 09/07/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Net 1 Ueps Technologies (UEPS) 13.71 $UEPS

Will Net 1 UEPS Technologies (UEPS) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:53AM CDT
Will Net 1 UEPS Technologies (UEPS) Continue to Surge Higher?

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Uptrend Call Working As Net 1 UEPS Technologies Stock Rises 24.7% (UEPS)
Comtex SmarTrend(R) - Tue Sep 02, 9:41AM CDT
SmarTrend identified an Uptrend for Net 1 UEPS Technologies (NASDAQ:UEPS) on February 12th, 2014 at $10.01. In approximately 7 months, Net 1 UEPS Technologies has returned 24.71% as of today's recent price of $12.49.

Net 1 UEPS Technologies Set to Possibly Pullback After Yesterday's Rally of 4.79%
Comtex SmarTrend(R) - Fri Aug 29, 4:50PM CDT
Net 1 UEPS Technologies (NASDAQ:UEPS) traded in a range yesterday that spanned from a low of $12.23 to a high of $13.38. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $11.76 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Net 1 UEPS Technologies (UEPS) Stock Continues To Gain Today
at The Street - Fri Aug 29, 10:24AM CDT
Net 1 UEPS Technologies (UEPS) stock is continuing to rise after the company reported an increase in 2014 fourth quarter net income and revenue that topped analysts' expectations.

Stock Futures Halve Early Gains; Avago, Splunk, Digital Ally Jump
at Investor's Business Daily - Fri Aug 29, 8:04AM CDT
Stock futures remained positive Friday, but shifted sharply off early highs after weak July income and spending data. Dow futures held 26.4 points above fair market value, about half of their earlier gains. Nasdaq 100 futures trimmed back to an...

Why Net1 UEPS Technologies (UEPS) Stock Is Soaring in After-Hours Trading Today
at The Street - Thu Aug 28, 3:41PM CDT
Shares of Net1 UEPS Technologies (UEPS) surged in after-hours trading Thursday after the company reported fourth-quarter earnings that crushed analysts' expectations.

Net1 UEPS Technologies, Inc. Reports 2014 Fourth Quarter and Full Year Results
Marketwire - Thu Aug 28, 3:06PM CDT
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS)(JSE: NT1) today released results for the fourth quarter and full-year fiscal 2014.

Shares of UEPS Up 10.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 26, 9:30AM CDT
SmarTrend identified an Uptrend for Net 1 UEPS Technologies (NASDAQ:UEPS) on February 12th, 2014 at $10.02. In approximately 7 months, Net 1 UEPS Technologies has returned 10.53% as of today's recent price of $11.07.

Net1 Brings Light to the Msinga Region of KZN
Marketwire - Mon Aug 18, 7:03AM CDT
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS)(JSE: NT1) recently hosted the Minister of Social Development, Mrs. Bathabile Dlamini, in the Msinga region of KwaZulu Natal, where the company donated furniture for a child-headed household, and distributed 500 Sun-e-light solar powered lamps to members of the local community.

Net 1 UEPS Technologies Has Returned 11.2% Since SmarTrend Recommendation (UEPS)
Comtex SmarTrend(R) - Mon Aug 11, 10:03AM CDT
SmarTrend identified an Uptrend for Net 1 UEPS Technologies (NASDAQ:UEPS) on February 12th, 2014 at $10.02. In approximately 6 months, Net 1 UEPS Technologies has returned 11.23% as of today's recent price of $11.14.

Allegion Disappoints Q2 Earnings on Weak US Housing Recovery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 1:00PM CDT
Allegion plc Ordinary Shares (ALLE), a leading provider of security products and solutions for homes and businesses, reported dismal second-quarter results, as both earnings as well as revenues missed the Zacks consensus Estimate.

TASER International Beats Q2 Earnings Estimates, Sales Jump - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 10:58AM CDT
TASER International Inc. (TASR) reported earnings of 7 cents per share during the second quarter 2014, beating the Zacks Consensus Estimate by 2 cents.

Net 1 UEPS Technologies, Inc. to Host Conference Call to Review Fourth Quarter and Full Year 2014 Results
Marketwire - Wed Jul 30, 7:31AM CDT
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS)(JSE: NT1) ("Net1" today announced it will release fourth quarter and full year 2014 results after the market close on August 28, 2014. Net1 management will host a conference call to review these results on August 29, 2014, at 8:00 a.m. Eastern Time.

Net1 Mobile Solutions Brings Light to Hundreds of Pupils at Jon Kotlolo School
Marketwire - Tue Jul 22, 6:41AM CDT
Net 1 UEPS Technologies Inc. (NASDAQ: UEPS)(JSE: NT1) today announced that its Net1 Mobile Solutions ("N1MS" business unit, partnered with other South African-based companies and organizations to bring care-packs to hundreds of pupils at Jon Kotlolo School, and surrounding community members, in Nellmapius, Pretoria, in celebration of Mandela Day, on July 18, the iconic leader's birthday.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading